Globeflex Capital L P Cytek Biosciences, Inc. Transaction History
Globeflex Capital L P
- $1.15 Billion
- Q4 2024
A detailed history of Globeflex Capital L P transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Globeflex Capital L P holds 84,434 shares of CTKB stock, worth $441,589. This represents 0.05% of its overall portfolio holdings.
Number of Shares
84,434Holding current value
$441,589% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding CTKB
# of Institutions
148Shares Held
73.3MCall Options Held
400Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$89.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$61.3 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD8.25MShares$43.1 Million1.27% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$34.8 Million1.65% of portfolio
-
State Street Corp Boston, MA4.51MShares$23.6 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $704M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...